Amos Grünebaum: The Cost of Ideology in Fertility Treatments
Amos Grünebaum, Professor of Obstetrics and Gynecology Donald and Barbara Zucker School of Medicine, shared at on LinkedIn:
“IVF, ‘Natural’ Medicine, and the Cost of Ideology
When fertility care is framed as a moral project rather than a medical one, patients pay the price. A new JAMA Viewpoint examines how so-called ‘restorative reproductive medicine’ restricts access to IVF and other evidence-based treatments, not because they are unsafe, but because they conflict with ideology. In this piece, I unpack why denying effective care in the name of ‘natural’ medicine is neither ethical nor patient-centered, and why this debate matters far beyond infertility clinics.
More here.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jun 15, 2026, 12:21Zara Grigoryan: Open Expert Dialogue to Shape Women’s Health in Armenia
-
Jun 15, 2026, 12:12Abhishek Saxena։ Can a 5PN Embryo Develop Normally?
-
Jun 15, 2026, 12:02Does Growth Hormone Help in IVF? – Fertility Plus
-
Jun 15, 2026, 11:55Allen Morgan: PRP in Fertility Treatment, Emerging Evidence and Future Directions
-
Jun 15, 2026, 11:49Hereditary Gynecologic Cancer Care Is Evolving, but Access and Health Systems Remain Unequal – IJGO
-
Jun 15, 2026, 11:41Celebrating Community and Support at the Annual Fertili’Tea Party! – CFAS
-
Jun 15, 2026, 11:37Christopher Robinson: Outcomes in Late Preterm and Term Births with Gestational Diabetes vs Normoglycemia
-
Jun 15, 2026, 11:34Registration Now Open for Fertility 2027 – British Fertility Society
-
Jun 15, 2026, 11:28Ioakeim Sapantzoglou: Excited to Share Our Latest Publication in Archives of Gynecology and Obstetrics!